Day: March 21, 2023

Akerna Announces Financial Results for Fourth Quarter and Full Year 2022

Written by Customer Service on March 21, 2023. Posted in Earnings Releases And Operating Results.

DENVER, March 21, 2023 (GLOBE NEWSWIRE) — Akerna (Nasdaq: KERN), an emerging technology firm, today reported its unaudited financial results for the fourth quarter, ended December 31, 2022. Key Developments:Akerna completed the sales of its 365 Cannabis and Last Call Analytics business units in January 2023 for combined consideration valued at approximately $2.9 million Akerna announced a proposed merger with Gryphon Digital Mining and the simultaneous proposed sale of its non-enterprise software business to POSaBIT on January 27, 2023 Gryphon, a leading net carbon neutral bitcoin miner, will be merging with Akerna by way of an Agreement and Plan of Merger to create a leading, ESG-committed, carbon-neutral bitcoin miner, subject to certain conditions of closing including but not limited to approval of the Nasdaq and stockholder...

Orgenesis Reports 98% Year-Over-Year Increase in Revenue to $13.6 Million for the Fourth Quarter of 2022

Written by Customer Service on March 21, 2023. Posted in Earnings Releases And Operating Results.

Rapid growth reflects progress of POCare Platform Orgenesis to host conference call today at 11:00 AM ET GERMANTOWN, Md., March 21, 2023 (GLOBE NEWSWIRE) — Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies (CGT), today provided a business update for the fourth quarter and year ended December 31, 2022. Vered Caplan, CEO of Orgenesis, said, “I am pleased to report that revenue for the fourth quarter of 2022 increased by 98% to $13.6 million, compared to $6.9 million for the same period last year as we are progressing with the planned rollout of our POCare platform. In addition to our strong revenue growth, we reduced our operating loss by 91% for the fourth quarter of 2022 versus the same period last year, which reflects our cost-effective...

Surgalign Schedules Fourth Quarter and Full Year 2022 Earnings Release for March 30, 2023

Written by Customer Service on March 21, 2023. Posted in Public Companies.

DEERFIELD, Ill., March 21, 2023 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced its plans to release financial results for its fourth quarter and full year 2022 after the close of trading on March 30, 2023. Surgalign will host a conference call and audio webcast at 4:30 p.m. ET the same day. The conference call can be accessed by dialing (866) 604-1616 (U.S.) or 201-689-8043 (International). The webcast can be accessed through the investor relations section of Surgalign’s website at www.surgalign.com/investors. A replay of the conference call will be available on Surgalign’s website for one month following the call. About Surgalign Holdings, Inc.Surgalign Holdings, Inc. is a global...

Canacol Energy Ltd. Achieves 169% 2P Reserve Replacement Ratio Increasing 2P Reserves to 652 Bcfe with a Before Tax Value of US$1.9 Billion

Written by Customer Service on March 21, 2023. Posted in Earnings Releases And Operating Results.

CALGARY, Alberta, March 21, 2023 (GLOBE NEWSWIRE) — Canacol Energy Ltd. (“Canacol” or the “Corporation”) (TSX:CNE; OTCQX:CNNEF; BVC:CNEC) is pleased to report its conventional natural gas and light/medium crude oil reserves for the fiscal year end December 31, 2022. The Corporation’s conventional natural gas reserves are located in the Lower Magdalena Valley basin, Colombia. Newly discovered light/medium crude oil reserves are located in the Middle Magdalena Valley basin, Colombia. Canacol Energy Ltd Gross Conventional Natural Gas and Light/Medium Crude Oil Reserves Summary(1)(5) Proved Developed Producing Total Proved Total Proved + Probable Total Proved + Probable + PossibleProduct Type (“PDP”) (“1P”) (“2P”) (“3P”)Conventional natural gas and light/medium...

Alignment Health taps new SVPs to steer growth in core markets, delivering high-quality, low-cost care to more seniors

Written by Customer Service on March 21, 2023. Posted in Public Companies.

Health care industry veterans Tim Moorhead, Lisa Ferrari to deepen relationships, strengthen operations in Arizona, California, Nevada, North Carolina, Texas ORANGE, Calif., March 21, 2023 (GLOBE NEWSWIRE) — Alignment Health, a consumer brand name of Alignment Healthcare, Inc. (NASDAQ: ALHC), a tech-enabled Medicare Advantage company that is championing a new path in senior care, today announced the appointment of Tim Moorhead as senior vice president and regional president of North Carolina, Arizona and Texas, and Lisa Ferrari as senior vice president and regional president of Nevada and Northern California. Reporting to Dawn Maroney, president of markets for Alignment Health, both executives will create customer value while ensuring strategic operating plans are being met in their respective markets. They also will collaborate...

OTC Markets Group Celebrates the Passing of ESOP Fairness Act Legislation

Written by Customer Service on March 21, 2023. Posted in Public Companies.

NEW YORK, March 21, 2023 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for 12,000 U.S. and international securities, celebrates the ESOP Fairness Act (S.3270) (H.R.5851), which was included in the SECURE Act 2.0 retirement package that was signed into law on December 29, 2022. We thank the lead sponsors Representative Brian Higgins (D-NY-26) and Senator Gary Peters (D-MI) who advocated for the inclusion of this important provision, along with Senators Thom Tillis (R-NC) and Kyrsten Sinema (D-AZ), and Representatives Mike Kelly (R-PA-16), Vern Buchanan (R-FL-16), Linda Sánchez (D-CA-38), Jackie Walorski (R-IN-2), Darin LaHood (R-IL-18) and Bill Pascrell (D-NJ-9). Employee Stock Ownership Plans (“ESOPs”) are benefit plans recognized under IRS regulations that allow companies to offer stock...

Quantum Computing Inc Appoints Security and Cryptography Expert Brian LaMacchia to Technical Advisory Board

Written by Customer Service on March 21, 2023. Posted in Public Companies.

LEESBURG, Va., March 21, 2023 (GLOBE NEWSWIRE) — Quantum Computing Inc. (“QCI” or the “Company”) (NASDAQ: QUBT), a first-to-market full-stack photonic-based quantum computing and solutions company, today announced the second appointment to its Technical Advisory Board launched on February 2, 2023. Effective immediately, Dr. Brian LaMacchia, joins US intelligence community veteran and technology strategist The Honorable James (Jim) Simon, Jr who heads the Board with the mission to guide and advance the strategic evolution of QCI’s technology while ensuring effective commercialization of product rollouts. Brian LaMacchia recently retired from Microsoft Corporation where he was a Distinguished Engineer and head of the Security and Cryptography team within Microsoft Research. Before retiring, his team’s main project was the development...

Bruno Rossi joins Olink as Chief Commercial Officer

Written by Customer Service on March 21, 2023. Posted in Public Companies.

Bruno Rossi Chief Commercial Officer, OlinkUPPSALA, Sweden , March 21, 2023 (GLOBE NEWSWIRE) — Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced the appointment of life sciences industry veteran Bruno Rossi to the role of Chief Commercial Officer (CCO), effective immediately. Mr. Rossi will lead the Company’s global commercial organization including Sales, Marketing and Sales Operations. He will report to Carl Raimond, President of Olink. “I am delighted to welcome Bruno to the Olink organization, and look forward to the value his considerable industry experience will add to our rapidly growing company.” said Carl Raimond, President of Olink. “Over the past two years, Olink has experienced remarkable growth. We have a deep and talented executive team that is well positioned to drive growth and sustain market leadership...

ProSomnus® Receives Patent Allowance Covering Automated Manufacturing Process for Company’s Novel Precision Sleep Apnea Medical Devices

Written by Customer Service on March 21, 2023. Posted in Public Companies.

PLEASANTON, Calif., March 21, 2023 (GLOBE NEWSWIRE) — ProSomnus, Inc. (“the Company”) (NASDAQ: OSA), a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced that the U.S. Patent and Trademark Office (USPTO) has allowed a patent application covering the Company’s proprietary automated manufacturing process for the Company’s precision medical devices; this is the third patent to issue in this family, including already-issued USPN 10,213,280 and USPN 9,808,327. ProSomnus’s intellectual property portfolio now includes 16 issued patents in the United States and other countries, encompassing more than 100 claims, in addition to trademarks, trade secrets and other patent applications in process. ProSomnus’s FDA-cleared, Precision OAT devices are a practical alternative to legacy oral...

Bruno Rossi joins Olink as Chief Commercial Officer

Written by Customer Service on March 21, 2023. Posted in Public Companies.

Bruno Rossi Chief Commercial Officer, OlinkUPPSALA, Sweden, March 21, 2023 (GLOBE NEWSWIRE) — Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced the appointment of life sciences industry veteran Bruno Rossi to the role of Chief Commercial Officer (CCO), effective immediately. Mr. Rossi will lead the Company’s global commercial organization including Sales, Marketing and Sales Operations. He will report to Carl Raimond, President of Olink. “I am delighted to welcome Bruno to the Olink organization, and look forward to the value his considerable industry experience will add to our rapidly growing company.” said Carl Raimond, President of Olink. “Over the past two years, Olink has experienced remarkable growth. We have a deep and talented executive team that is well positioned to drive growth and sustain market leadership...

Day: March 21, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice